Evidence map›Paper›PMID 39195924›Full record

ArticleNature cardiovascular research2023

Calcineurin signaling promotes takotsubo syndrome.

Bastian Bruns, Marilena Antoniou, Irena Baier, Maximilian Joos, Meryem Sevinchan, Marie-Christine Moog, Christoph Dieterich, Hans-Christoph Friederich, Hilal Khan, Heather Wilson and 5 more

Abstract read
In one paragraph

Article in Nature cardiovascular research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Immunology of Takotsubo Syndrome.Frontiers in immunology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Bastian BrunsInstitute of Experimental Cardiology, Heidelberg University Hospital, Heidelberg, Germany.
Marilena AntoniouInstitute of Experimental Cardiology, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-4393-0182
Irena BaierInstitute of Experimental Cardiology, Heidelberg University Hospital, Heidelberg, Germany.
Maximilian JoosInstitute of Experimental Cardiology, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0003-2260-3964
Meryem SevinchanInstitute of Experimental Cardiology, Heidelberg University Hospital, Heidelberg, Germany.
Marie-Christine MoogInstitute of Experimental Cardiology, Heidelberg University Hospital, Heidelberg, Germany.
Christoph DieterichDepartment of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, Heidelberg, Germany.
Hans-Christoph FriederichDepartment of General Internal Medicine and Psychosomatics, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0003-4344-8959
Hilal KhanCardiology Research Group, Aberdeen Cardiovascular and Diabetes Centre, School of Medicine and Dentistry, University of Aberdeen, Aberdeen, UK.ORCID 0000-0003-0412-2227
Heather WilsonCardiology Research Group, Aberdeen Cardiovascular and Diabetes Centre, School of Medicine and Dentistry, University of Aberdeen, Aberdeen, UK.ORCID 0000-0002-1407-7274
Wolfgang HerzogDepartment of General Internal Medicine and Psychosomatics, Heidelberg University Hospital, Heidelberg, Germany.
Dana K DawsonCardiology Research Group, Aberdeen Cardiovascular and Diabetes Centre, School of Medicine and Dentistry, University of Aberdeen, Aberdeen, UK.
Norbert FreyDepartment of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, Heidelberg, Germany.
Jobst-Hendrik SchultzDepartment of General Internal Medicine and Psychosomatics, Heidelberg University Hospital, Heidelberg, Germany.
Johannes BacksInstitute of Experimental Cardiology, Heidelberg University Hospital, Heidelberg, Germany. johannes.backs@cardioscience.uni-heidelberg.de.ORCID 0000-0002-2322-2699

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) CRC1550, INST 35/1699-1Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg (Ministry of Science, Research and Art Baden-Württemberg) Innovationcampus Rhein-Neckar
6 · The paper itself

Abstract

Takotsubo syndrome (TTS) is an acute heart failure syndrome that mimics the symptoms of acute myocardial infarction and is often preceded by emotional and/or physical stress. There is currently no treatment for TTS. Here we show that injection of 2.5 mg kg

Indexed as

CalcineurinCalcineurin InhibitorsDisease Models, AnimalEpinephrineSignal TransductionTakotsubo CardiomyopathyAnimalsCalcium-Binding ProteinsCyclosporineFemaleGene Regulatory NetworksHumansMaleMiceMice, Inbred C57BLMuscle ProteinsCalcineurinCalcineurin InhibitorsCalcium-Binding ProteinsCyclosporineDSCR1 protein, mouseEpinephrineMuscle ProteinsTacrolimus

Identifiers

PMID39195924
PMCPMC11358029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.